Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Caz, I just got off the phone with Frank. And their is an appeal to the SEC charges against Frank that I will post tomorrow. Also, don't loose faith!!! I can tell you that SVFC is going to have some big pr's coming up very soon! All these petty games will mean nothing when we start getting the news! I'm buying as much as I can!!!!
Go SVFC
..
Yes this is confirmed as it was my post and I just received an email that I posted as well. So now that this is fact. How does this change the FACT that SVFC has many highly respected world renowned people on the board..
You know what... Never mind!
I know what I own and I know what I will be buying more of
Go SVFC
..
Let's put this to rest...
I emailed frank and received this reply.
Hi xxxx, My SEC attorney Robert Heim is handling this and we are confident that this will be dismissed.
I have 28 years in this business with no regulatory issues.
I would welcome the opportunity to speak with you if needed
Thanks
Frank
Frank Lorenzo
Phone: 551 427 8476
Fax: 201 829 0845
SVFC bounced off the bottom of .0009 and closed.0011 up 10%
Watch for big moves in the coming days!!
I should just sell one share @ .0009 and get it out of the way! Then we can move up!!
Go SVFC
..
That's right roller!!
SVFC-Someone bought 147.5 MILLION SHARES!!!
http://ih.advfn.com/p.php?pid=nmona&article=63546602&symbol=SVFC
Go SVFC
..
Stem cells are the future of medicine
Cancer Treatment Centers of America® at Midwestern Regional Medical Center Recognized for Exemplary Stem Cell Treatment and Cell Therapy Program
Hospital Awarded Accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT)
CANCER TREATMENT CENTERS OF AMERICA,
September 30, 2014
SHARE
Story
ZION, Ill., Sept. 30, 2014 — /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA®) at Midwestern Regional Medical Center (Midwestern) has been recognized by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration.
FACT, an internationally-recognized accrediting body for hospitals and medical institutions offering stem cell transplant, awarded CTCA at Midwestern with the prestigious accreditation for meeting rigorous standards in a variety of stem cell therapies, including clinical care, donor management, cell collection, processing, storage, transportation, administration and cell release. As a member of the National Marrow Donor Program (NMDP®), CTCA at Midwestern offers a Stem Cell Transplant and Cell Therapy program that provides a full spectrum of transplantation services and advanced treatment options for hematologic cancers.
"It is with great pride that CTCA at Midwestern receives the esteemed FACT accreditation," said Scott Jones president and CEO of CTCA at Midwestern. "This is a tremendous milestone for our Stem Cell Treatment and Cell Therapy Program and evidence of the quality of care our exceptional team provides to our patients on a daily basis."
FACT accreditation is attained through evaluation of detailed clinical documentation and an on-site inspection to determine if an organization is in compliance with current FACT standards and the United States Food and Drug Administration's rules for Good Tissue Practice. FACT Standards are defined by leading experts based on the latest knowledge of the field of cellular therapy. Since 2007, FACT accreditation has been used in determining the U.S. News & World Report rankings of transplant centers for the "America's Best Hospitals" and "America's Best Children's Hospitals" lists.
"Our Stem Cell Treatment and Cell Therapy Program provides world-class care to each patient throughout the duration of their stay at the hospital and beyond," said Istvan Redei, MD, national director of stem cell transplant and cell therapy and hematologist-oncologist at CTCA at Midwestern. "Receiving FACT accreditation is a great honor and will demonstrate to patients that they are in good hands."
To learn more about FACT accreditation or view a full list of accredited organizations, visit www.factwebsite.org. For more information on CTCA at Midwestern, visit www.cancercenter.com.
About Cancer Treatment Centers of America® Cancer Treatment Centers of America, Inc. (CTCA) is a national network of five hospitals that specialize in the treatment of patients fighting complex or advanced-stage cancer. CTCA offers an integrative approach to cancer treatment that combines surgery, radiation, and chemotherapy with nutritional counseling, naturopathic medicine, mind-body therapy, and spiritual support to enhance quality of life and minimize side effects during treatment. The company serves patients from all 50 states at hospitals located in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Known for delivering the Mother Standard® of care and Patient Empowerment Medicine®, CTCA provides patients with comprehensive information about their treatment options so they can participate in their treatment decisions. For more information about CTCA, go to www.cancercenter.com.
About Cancer Treatment Centers of America at Midwestern Regional Medical Center Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center is a 73 bed specialty hospital dedicated to treating patients battling complex cancer. CTCA® at Midwestern is nationally recognized for providing innovative and individualized cancer care and has been designated by the American Nurses Credentialing Center (ANCC) a Magnet Recognized® program, ranking the hospital as one of the top seven percent in the nation for nursing excellence. CTCA at Midwestern has been designated by the National Quality Measures for Breast Centers Program (NQMBC®) as a Certified Quality Breast Center of Excellence™, ranking the hospital among the top centers in the country for quality breast cancer care. CTCA at Midwestern is the only Certified Breast Center of Excellence in Illinois, and one of only 41 nationally. As a member of the National Marrow Donor Program (NMDP) the hospital also offers a Stem Cell Transplant and Cell Therapy program that provides a full spectrum of transplantation services and advanced treatment options for hematologic cancers. CTCA is recognized by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration. CTCA at Midwestern is also recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO), for meeting the highest standards for quality cancer care. CTCA at Midwestern is proud to use the latest technology to offer advanced treatment for cancer and is currently one of only a few hospitals in the nation to combine recent advances in brain mapping and navigation to perform minimally invasive brain surgery on hard to reach brain tumors.
Logo - http://photos.prnewswire.com/prnh/20090612/CTCALOGO Logo - http://photos.prnewswire.com/prnh/20140930/149373
SOURCE Cancer Treatment Centers of America
Read more here: http://www.sacbee.com/2014/09/30/6748581/cancer-treatment-centers-of-america.html#storylink=cpy
Go SVFC
..
SVFC getting is stronger every day! You can just feel the momentum building!!
Soon, very soon my friend!!!
Go SVFC
..
Lol lmao!! Pec(ker)
Go SVFC
..
Don't forget about this guy! He is betting SVFC will go up!
SVFC-Someone bought 147.5 MILLION SHARES!!!-SEC-Filing-OUT...
http://ih.advfn.com/p.php?pid=nmona&article=63546602&symbol=SVFC
Go SVFC
..
See ya soon!!
Go SVFC
..
Sale ends soon!! Get your tickets now!
Go SVFC
..
Do you have your tickets for the show?!!!
Go SVFC
..
IntelliCell BioSciences' Stem Cell Technology Validated by Merck Subsidiary
NEW YORK, NY--(Jul 14, 2011 07:00 ET) - IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult stem cells, today announced that an antibody flow cytometry study of IntelliCell's technology was performed by Millipore, a division of Merck, a life science leader providing cutting-edge technologies, tools and services for bioscience research and biopharmaceutical manufacturing.
The results of the study conclude that IntelliCells? manufactured by IntelliCell's proprietary technology yield an average of 10 times (10X) the number of SVF cells containing adult adipose stem cells from less fat (only 2 oz) than that which the Company believes is used by any of its present competition utilizing enzymes in their process. The study also showed that IntelliCells? contain all of the viable cells that are manufactured by competing technologies that use enzymatic digestion.
"We believe IntelliCell is setting the gold standard for adipose stem cell processing without the use of enzymes and yielding high number of SVFs with adult adipose stem cell counts. We feel that our technology is a true game changer in the field of regenerative medicine and that SVF could show incredible promise for a wide range of clinical uses in the near future," stated IntelliCell Chairman and CEO, Dr. Steven Victor.
"We believe that the body stores all of the reparative and regenerative cells it could possibly need as a result of trauma or illness in the stromal vascular fraction (SVF) contained in the fat. We are very pleased with the results of Millipore's study as it does confirm that at least four of these pluripotent stem cell types are indeed existent in this tissue, and our technology has, for the very first time in history, unlocked these cells which have similar potential to embryonic stem cells in their pluripotency, in vast number, from a source that entails no moral controversy, and no chemical additives required for digestion of the tissue -- requiring only minimal, mechanical manipulation of the tissue as defined by the FDA's rule 361," concluded Dr. Steven Victor.
The use of autologous adipose (fat) stem cells has become a new and exciting frontier in medicine. Numerous doctors, companies and researchers are studying the use of these adipose stem cells for applications that include the treatment of arthritis and numerous orthopedic injuries such as knees, elbows and shoulders; wound healing; back pain; congestive heart failure; gum recession; and fat augmentation for breast, buttock and face; as well as other disease states.
In the aesthetic world, the use of autologous adipose stem cells has become widely accepted in Europe and Asia. Since the middle of 2009 when the US FDA published its laws on autologous stem cells the field has expanded rapidly.
IntelliCell has developed an in-house technology where it can easily process stromal vascular cells containing a high concentration of adipose stem cells with excellent viability. At present, management believes it is the only company that does not use enzymes in processing adipose tissue and actually counts and checks the adipose stem cells they manufacture.
The adipose stem cell processing technique of IntelliCell takes approximately 30 minutes and the stem cells can be returned to the doctor in the same day. Autologous Adipose Stem Cells are on the cutting edge of medicine and IntelliCell is excited to be one of the premier companies to participate in this field.
About IntelliCell Biosciences, Inc.
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using stromal vascular fraction derived from adult adipose tissue. IntelliCell intends to initially focus on setting up tissue processing centers throughout the United States with managing partners. The centers will receive and employ the IntelliCell™ process to the adipose stromal vascular fraction harvested by physicians in their own offices, and then return the IntelliCells™ to the physicians the same day labeled "autologous homologous." IntelliCell has already established processing centers in New York City, Philadelphia, Dallas/Ft. Worth, and New Orleans, and has entered into a licensing agreement for a center in Palm Beach. In the future, IntelliCell intends to pursue expansion to secondary markets and beyond the U.S. through a combination of company-owned and licensed clinical facilities. For additional information, visit http://www.intellicellbiosciences.com or call 212 249 3050.
Forward-Looking Statements
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contact Information
Investor Relations for IntelliCell BioSciences Inc.
Go SVFC
..
Watch the volume closely over the next few trading sessions! Things are getting ready to explode upwards!!!
Go SVFC
..
I agree! STO at 4.76 is in MAJOR OVERSOLD TERRITORY!!!
http://stockcharts.com/h-sc/ui?s=SVFC
Go SVFC
..
I agree! STO at 4.76 is in MAJOR OVERSOLD TERRITORY!!!
http://stockcharts.com/h-sc/ui?s=SVFC
Go SVFC
..
You are neglecting to look at both sides of the coin. Yes only interest( positive interest) will help SVFC . But negative interest (bashing) can hurt SVFC. And has! Now what we need to ask ourselves is... How much more will they be able to bring it down? I would argue that they have exhausted their ability to influence the pps any lower! So... Now what? If SVFC won't go any lower then it will either stay steady (where nobody makes money) or we Go up and the MM's start to sell some of the shares that they have been accumulating at higher and higher pps!!
SVFC is going up!!!
..
Me too Larry! Lol!! hang tight we are ready to roll!
Go SVFC
..
I believe that you are making a big mistake if you think the next run will be short lived! SVFC is on the verge of a major breakout that will last years! That is of course if big pharma doesn't step in with huge a buyout offer! Again.... Don't listen to me, and go ahead and short, sell or take profits when this starts to run. I don't care!! But mark my words.... SVFC is about to make history! And it's going to be biblical!!!
Go SVFC
..
And MM's covering! Don't listen to me. I don't care. But I am right!!
Go SVFC
..
WRONG!!!!!
There has been a concerted effort to bring the pps down by the MM's and the shorts have taken advantage of it and brought it to these extremely undervalued levels!! If you don't believe me, just watch what happens when the MM's let go of the reins and the shorts start to cover!!
It's coming. Make no mistake about it!!
Go SVFC
..
I have a feeling we will be seeing her wearing green a lot more!!
Go SVFC
..
Oops!!
Go SVFC
..
I tried to tell ya to cover and buy as many shares as possible!! I hope you were listening!!! Better late than never!
SVFC is going up!!!
..
I've been trying to tell ya to cover your short positions and add as many shares as possible!
I sure hope you were listening !!!!!
Go SVFC
..
Thanks for the update!
Go SVFC
..
Today's volume in dollars was less than $3,500 just MM's shaking the tree with $100 - $200 trades!
Ask yourself this....
What happens when no more apples fall out of the tree? Do they cut the tree down? Or do they begin to nourish the tree and let it produce more apples?
I know what I would do. I also know that if they hang out under the tree to long one day a big squirrel is going to take a big dump on their heads!
Go SVFC
..
Take some time and read this over. Then tell me that you don't think the MM's are responsible for the very low pps and... are covering and adding to shares to prepare for the inevitable run!!!
Some ways MM's entice sellers; Run the stock up with a "tight spread" in a fast market, then "open" up the spread to slow down the buying interest. After it has "cooled off" for a little while lower the offer below the last trade right after a small piece trades on the offer then tighten the spread so that the sellers feel they can take a "quick profit" by "hitting the bid" on the tight spread.
Once the selling starts the MM's will walk it down quickly by only making small prints on the way down with the tight spread. Another way is by running the stock up in the morning, averaging up their short then use the above technique to walk it down in the afternoon.
Hopefully after doing this for several days, it will demoralize the buyers. The volume will dry up and the sellers will materialize thinking that the game is over.
Contrary to popular opinion, MM usually Do Not Cover in Fast moving markets either Up or Down if they are short. They Short More. They usually try to cover after the frenzy is out of the market. There are many other techniques they use but the above are the most popular.
This technique works about 9 times out of 10 particularly in a BB market. However that is because 9 out of 10 BB stocks are BS. Remember what I said above. Most MM's don't have a clue as to the value of a Company until they get trapped. If the Company has solid fundementals and a bright future. Then the stock will do very well. And the activity that caused the situation will prove to even help the future stock activity because it created an audience."
Go SVFC
..
The MM's don't care about any stock! But they sell shares in all stocks! MM's need to cover and add shares to sell when the inevitable move up happens!!
Go SVFC
..
Who is we?? The MM's are covering!!!
Just sayin...
Go SVFC
..
The best time to buy is when there is blood in the streets and people are screaming sell!!!
Go SVFC
..
Wow!!! Great video!! This should go viral!!! Thanks for posting
Investors don't make money by selling when a stock goes down and then buying back in after it runs up.
Be careful, SVFC is on the verge of a major breakout!!!
Go SVFC
..
This is OLD!! From August 18th!! And then it was old from June I believe!!!
SVFC has paid IR per court order and soon UR will be paying SVFC punitive damages in the millions!! Mark my words
Go SVFC
..
Mm's are loading up and smart investors would be wise to do the same. SVFC is going to make "going to da moon" look like child's play!
SVFC going to the outer limits of the known universe!
Go SVFC
..
Maybe SVFC isn't a dot com. But it is in the health care industry! And big changes are happening and will continue! Stem cells will be a big part of that and SVFC will have a major roll to play!!
Go SVFC
..
Can't wait to eat! Smells yummy!!!
Go SVFC
..
SVFC ready to breakout!!
http://stockcharts.com/h-sc/ui?s=SVFC
http://vimeo.com/m/58308970
Go SVFC
..